Natixis Investment Managers International’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-4,013
Closed -$1.95M 309
2022
Q2
$1.95M Buy
4,013
+766
+24% +$379K 0.04% 139
2022
Q1
$1.59M Buy
+3,247
New +$1.48M 0.03% 152
2018
Q4
Sell
-9,610
Closed -$2.63M 197
2018
Q3
$2.63M Buy
9,610
+1,297
+16% +$337K 0.12% 135
2018
Q2
$1.98M Sell
8,313
-1,956
-19% -$453K 0.11% 134
2018
Q1
$2.26M Buy
+10,269
New +$2.41M 0.16% 84
2017
Q4
Sell
-4,625
Closed -$878K 230
2017
Q3
$878K Buy
4,625
+3,910
+547% +$744K 0.08% 180
2017
Q2
$135K Sell
715
-44
-6% -$7.91K 0.01% 335
2017
Q1
$126K Sell
759
-804
-51% -$128K 0.01% 337
2016
Q4
$225K Sell
1,563
-3,330
-68% -$446K 0.02% 330
2016
Q3
$613K Hold
4,893
0.06% 217
2016
Q2
$643K Buy
4,893
+2,419
+98% +$331K 0.07% 193
2016
Q1
$344K Buy
2,474
+110
+5% +$14.7K 0.04% 251
2015
Q4
$330K Buy
2,364
+2,209
+1,425% +$304K 0.04% 222
2015
Q3
$22K Sell
155
-2,843
-95% -$427K ﹤0.01% 421
2015
Q2
$492K Buy
+2,998
New +$479K 0.06% 193

Other funds holding ELV

Natixis Investment Managers International's ELV Position: Q3 2022 in Review

Natixis Investment Managers International sold out of Elevance Health (ELV) in Q3 2022, closing a stake of 4,013 shares — an estimated $1.95M sold.

Natixis Investment Managers International first reported a position in ELV in Q2 2015 and held it in 15 quarters. The position peaked at $2.63M in Q3 2018. 1,446 funds tracked by Wall St. Rank hold ELV as of Q3 2022.

  • Natixis Investment Managers International reported no remaining Elevance Health position as of Q3 2022 after selling out during the quarter.
  • Natixis Investment Managers International sold 4,013 Elevance Health shares in Q3 2022, an estimated $1.95M.
  • Natixis Investment Managers International first reported a position in Elevance Health in Q2 2015 and held it in 15 quarters.
  • Natixis Investment Managers International's Elevance Health position peaked at $2.63M in Q3 2018.
  • 1,446 funds tracked by Wall St. Rank held Elevance Health as of Q3 2022.

Based on Natixis Investment Managers International's 13F filing for Q3 2022, filed 14 Nov 2022.